ID   PDXH_ECOLI              Reviewed;         218 AA.
AC   P0AFI7; P28225;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 102.
DE   RecName: Full=Pyridoxine/pyridoxamine 5'-phosphate oxidase;
DE            EC=1.4.3.5 {ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:7860596, ECO:0000269|PubMed:9693059};
DE   AltName: Full=PNP/PMP oxidase;
DE            Short=PNPOx;
DE   AltName: Full=Pyridoxal 5'-phosphate synthase;
GN   Name=pdxH; OrderedLocusNames=b1638, JW1630;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=1356963; DOI=10.1128/jb.174.19.6033-6045.1992;
RA   Lam H.-M., Winkler M.E.;
RT   "Characterization of the complex pdxH-tyrS operon of Escherichia coli
RT   K-12 and pleiotropic phenotypes caused by pdxH insertion mutations.";
RL   J. Bacteriol. 174:6033-6045(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M.,
RA   Makino K., Miki T., Mizobuchi K., Mori H., Mori T., Motomura K.,
RA   Nakade S., Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N.,
RA   Sampei G., Seki Y., Sivasundaram S., Tagami H., Takeda J.,
RA   Takemoto K., Takeuchi Y., Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-11, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=7860596; DOI=10.1128/jb.177.4.883-891.1995;
RA   Zhao G., Winkler M.E.;
RT   "Kinetic limitation and cellular amount of pyridoxine (pyridoxamine)
RT   5'-phosphate oxidase of Escherichia coli K-12.";
RL   J. Bacteriol. 177:883-891(1995).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR,
RP   AND SUBUNIT.
RX   PubMed=9693059; DOI=10.1006/prep.1998.0904;
RA   di Salvo M., Yang E., Zhao G., Winkler M.E., Schirch V.;
RT   "Expression, purification, and characterization of recombinant
RT   Escherichia coli pyridoxine 5'-phosphate oxidase.";
RL   Protein Expr. Purif. 13:349-356(1998).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 20-218 IN COMPLEX WITH FMN,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=10903950; DOI=10.1016/S0969-2126(00)00162-3;
RA   Safo M.K., Mathews I., Musayev F.N., di Salvo M.L., Thiel D.J.,
RA   Abraham D.J., Schirch V.;
RT   "X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase
RT   complexed with FMN at 1.8-A resolution.";
RL   Structure 8:751-762(2000).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEXES WITH PYRIDOXAL
RP   5'-PHOSPHATE AND FMN, COFACTOR, AND SUBUNIT.
RX   PubMed=11453690; DOI=10.1006/jmbi.2001.4734;
RA   Safo M.K., Musayev F.N., di Salvo M.L., Schirch V.;
RT   "X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase
RT   complexed with pyridoxal 5'-phosphate at 2.0 A resolution.";
RL   J. Mol. Biol. 310:817-826(2001).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   5'-PHOSPHATE AND FMN, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-14; TYR-17; ASP-49;
RP   ARG-197 AND HIS-199, AND COFACTOR.
RX   PubMed=11786019; DOI=10.1006/jmbi.2001.5254;
RA   di Salvo M.L., Ko T.-P., Musayev F.N., Raboni S., Schirch V.,
RA   Safo M.K.;
RT   "Active site structure and stereospecificity of Escherichia coli
RT   pyridoxine-5'-phosphate oxidase.";
RL   J. Mol. Biol. 315:385-397(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   5'-PHOSPHATE AND FMN, COFACTOR, AND SUBUNIT.
RX   PubMed=15858270; DOI=10.1107/S0907444905005512;
RA   Safo M.K., Musayev F.N., Schirch V.;
RT   "Structure of Escherichia coli pyridoxine 5'-phosphate oxidase in a
RT   tetragonal crystal form: insights into the mechanistic pathway of the
RT   enzyme.";
RL   Acta Crystallogr. D 61:599-604(2005).
CC   -!- FUNCTION: Catalyzes the oxidation of either pyridoxine 5'-
CC       phosphate (PNP) or pyridoxamine 5'-phosphate (PMP) into pyridoxal
CC       5'-phosphate (PLP). {ECO:0000269|PubMed:11786019,
CC       ECO:0000269|PubMed:7860596, ECO:0000269|PubMed:9693059}.
CC   -!- CATALYTIC ACTIVITY: Pyridoxamine 5'-phosphate + H(2)O + O(2) =
CC       pyridoxal 5'-phosphate + NH(3) + H(2)O(2).
CC       {ECO:0000269|PubMed:11786019, ECO:0000269|PubMed:7860596,
CC       ECO:0000269|PubMed:9693059}.
CC   -!- CATALYTIC ACTIVITY: Pyridoxine 5'-phosphate + O(2) = pyridoxal 5'-
CC       phosphate + H(2)O(2). {ECO:0000269|PubMed:11786019,
CC       ECO:0000269|PubMed:7860596, ECO:0000269|PubMed:9693059}.
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:10903950,
CC         ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:11786019,
CC         ECO:0000269|PubMed:15858270, ECO:0000269|PubMed:7860596,
CC         ECO:0000269|PubMed:9693059};
CC       Note=Binds 1 FMN per subunit. {ECO:0000269|PubMed:10903950,
CC       ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:11786019,
CC       ECO:0000269|PubMed:15858270, ECO:0000269|PubMed:7860596,
CC       ECO:0000269|PubMed:9693059};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.3 uM for pyridoxamine 5'-phosphate
CC         {ECO:0000269|PubMed:11786019};
CC         KM=2 uM for pyridoxine 5'-phosphate (at pH 7.6 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:7860596,
CC         ECO:0000269|PubMed:9693059};
CC         KM=105 uM for pyridoxamine 5'-phosphate (at pH 7.6 and 37
CC         degrees Celsius) {ECO:0000269|PubMed:7860596};
CC         Note=Kcat is 0.3 sec(-1) for oxidase activity with pyridoxine
CC         5'-phosphate as substrate (at pH 7.6 and 37 degrees Celsius).
CC         {ECO:0000269|PubMed:9693059};
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage;
CC       pyridoxal 5'-phosphate from pyridoxamine 5'-phosphate: step 1/1.
CC   -!- PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage;
CC       pyridoxal 5'-phosphate from pyridoxine 5'-phosphate: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10903950,
CC       ECO:0000269|PubMed:11453690, ECO:0000269|PubMed:11786019,
CC       ECO:0000269|PubMed:15858270, ECO:0000269|PubMed:7860596,
CC       ECO:0000269|PubMed:9693059}.
CC   -!- MISCELLANEOUS: Can bind a second molecule of pyridoxamine 5'-
CC       phosphate at a non-catalytic site in a cleft at the protein
CC       surface.
CC   -!- SIMILARITY: Belongs to the pyridoxamine 5'-phosphate oxidase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92351; AAA24709.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74710.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15399.1; -; Genomic_DNA.
DR   PIR; B43261; B43261.
DR   RefSeq; NP_416155.1; NC_000913.3.
DR   RefSeq; WP_001282319.1; NZ_LN832404.1.
DR   PDB; 1DNL; X-ray; 1.80 A; A=20-218.
DR   PDB; 1G76; X-ray; 2.20 A; A=1-218.
DR   PDB; 1G77; X-ray; 2.10 A; A=1-218.
DR   PDB; 1G78; X-ray; 2.20 A; A=1-218.
DR   PDB; 1G79; X-ray; 2.00 A; A=1-218.
DR   PDB; 1JNW; X-ray; 2.07 A; A=1-218.
DR   PDB; 1WV4; X-ray; 2.60 A; A/B=1-218.
DR   PDBsum; 1DNL; -.
DR   PDBsum; 1G76; -.
DR   PDBsum; 1G77; -.
DR   PDBsum; 1G78; -.
DR   PDBsum; 1G79; -.
DR   PDBsum; 1JNW; -.
DR   PDBsum; 1WV4; -.
DR   ProteinModelPortal; P0AFI7; -.
DR   SMR; P0AFI7; -.
DR   DIP; DIP-48024N; -.
DR   IntAct; P0AFI7; 13.
DR   STRING; 511145.b1638; -.
DR   DrugBank; DB03345; Beta-Mercaptoethanol.
DR   DrugBank; DB03247; Riboflavin Monophosphate.
DR   EPD; P0AFI7; -.
DR   PaxDb; P0AFI7; -.
DR   PRIDE; P0AFI7; -.
DR   EnsemblBacteria; AAC74710; AAC74710; b1638.
DR   EnsemblBacteria; BAA15399; BAA15399; BAA15399.
DR   GeneID; 946806; -.
DR   KEGG; ecj:JW1630; -.
DR   KEGG; eco:b1638; -.
DR   PATRIC; 32118578; VBIEscCol129921_1709.
DR   EchoBASE; EB1450; -.
DR   EcoGene; EG11487; pdxH.
DR   eggNOG; ENOG4108S7T; Bacteria.
DR   eggNOG; COG0259; LUCA.
DR   HOGENOM; HOG000242755; -.
DR   InParanoid; P0AFI7; -.
DR   KO; K00275; -.
DR   OMA; PEHWGGY; -.
DR   PhylomeDB; P0AFI7; -.
DR   BioCyc; EcoCyc:PDXH-MONOMER; -.
DR   BioCyc; MetaCyc:PDXH-MONOMER; -.
DR   BRENDA; 1.4.3.5; 2026.
DR   UniPathway; UPA01068; UER00304.
DR   UniPathway; UPA01068; UER00305.
DR   EvolutionaryTrace; P0AFI7; -.
DR   PRO; PR:P0AFI7; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0010181; F:FMN binding; IDA:EcoCyc.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:EcoliWiki.
DR   GO; GO:0004733; F:pyridoxamine-phosphate oxidase activity; IDA:EcoCyc.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:EcoliWiki.
DR   GO; GO:0009443; P:pyridoxal 5'-phosphate salvage; EXP:EcoCyc.
DR   GO; GO:0008615; P:pyridoxine biosynthetic process; IDA:EcoCyc.
DR   Gene3D; 2.30.110.10; -; 1.
DR   HAMAP; MF_01629; PdxH; 1.
DR   InterPro; IPR000659; Pyridox_Oxase.
DR   InterPro; IPR019740; Pyridox_Oxase_CS.
DR   InterPro; IPR011576; Pyridox_Oxase_FMN-bd.
DR   InterPro; IPR019576; Pyridoxamine_oxidase_dimer_C.
DR   InterPro; IPR012349; Split_barrel_FMN-bd.
DR   PANTHER; PTHR10851:SF4; PTHR10851:SF4; 1.
DR   Pfam; PF10590; PNPOx_C; 1.
DR   Pfam; PF01243; Pyridox_oxidase; 1.
DR   PIRSF; PIRSF000190; Pyd_amn-ph_oxd; 1.
DR   SUPFAM; SSF50475; SSF50475; 1.
DR   TIGRFAMs; TIGR00558; pdxH; 1.
DR   PROSITE; PS01064; PYRIDOX_OXIDASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Flavoprotein; FMN; Oxidoreductase; Pyridoxine biosynthesis;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7860596}.
FT   CHAIN         2    218       Pyridoxine/pyridoxamine 5'-phosphate
FT                                oxidase.
FT                                /FTId=PRO_0000167706.
FT   NP_BIND      67     72       FMN. {ECO:0000269|PubMed:10903950,
FT                                ECO:0000269|PubMed:11453690,
FT                                ECO:0000269|PubMed:15858270}.
FT   NP_BIND      82     83       FMN. {ECO:0000269|PubMed:10903950,
FT                                ECO:0000269|PubMed:11453690,
FT                                ECO:0000269|PubMed:15858270}.
FT   NP_BIND     146    147       FMN. {ECO:0000269|PubMed:10903950,
FT                                ECO:0000269|PubMed:11453690,
FT                                ECO:0000269|PubMed:15858270}.
FT   REGION       14     17       Substrate binding.
FT                                {ECO:0000269|PubMed:11786019}.
FT   REGION      197    199       Substrate binding.
FT                                {ECO:0000269|PubMed:11786019}.
FT   BINDING      72     72       Substrate. {ECO:0000269|PubMed:11453690}.
FT   BINDING      88     88       FMN. {ECO:0000269|PubMed:10903950,
FT                                ECO:0000269|PubMed:11453690,
FT                                ECO:0000269|PubMed:15858270}.
FT   BINDING      89     89       FMN. {ECO:0000269|PubMed:10903950,
FT                                ECO:0000269|PubMed:11453690,
FT                                ECO:0000269|PubMed:15858270}.
FT   BINDING     111    111       FMN. {ECO:0000269|PubMed:11786019,
FT                                ECO:0000269|PubMed:15858270}.
FT   BINDING     129    129       Substrate. {ECO:0000269|PubMed:11453690}.
FT   BINDING     133    133       Substrate. {ECO:0000269|PubMed:11453690}.
FT   BINDING     137    137       Substrate. {ECO:0000269|PubMed:11453690}.
FT   BINDING     191    191       FMN. {ECO:0000269|PubMed:15858270}.
FT   BINDING     201    201       FMN. {ECO:0000269|PubMed:11786019,
FT                                ECO:0000269|PubMed:15858270}.
FT   MUTAGEN      14     14       R->E: Reduces affinity for substrate
FT                                about 7-fold, but has no effect on
FT                                catalytic activity.
FT                                {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN      14     14       R->M: Reduces affinity for substrate
FT                                about 9-fold, but has no effect on
FT                                catalytic activity.
FT                                {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN      17     17       Y->F: Reduces affinity for substrate 3-
FT                                fold, but has about 5-fold increase in
FT                                catalytic activity.
FT                                {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN      49     49       D->A: Reduces affinity for substrate 3-
FT                                fold and catalytic activity 2-fold.
FT                                {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN     197    197       R->E: Reduces affinity for substrate
FT                                8000-fold and catalytic activity 16-fold.
FT                                {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN     197    197       R->M: Reduces affinity for substrate 300-
FT                                fold and catalytic activity about 4-fold.
FT                                {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN     199    199       H->A: Reduces affinity for substrate 230-
FT                                fold, but has no effect on catalytic
FT                                activity. {ECO:0000269|PubMed:11786019}.
FT   MUTAGEN     199    199       H->N: Reduces catalytic activity about 4-
FT                                fold, but has no effect on affinity for
FT                                substrate. {ECO:0000269|PubMed:11786019}.
FT   HELIX         9     12       {ECO:0000244|PDB:1JNW}.
FT   HELIX        24     26       {ECO:0000244|PDB:1DNL}.
FT   HELIX        31     44       {ECO:0000244|PDB:1DNL}.
FT   STRAND       52     58       {ECO:0000244|PDB:1DNL}.
FT   STRAND       64     70       {ECO:0000244|PDB:1DNL}.
FT   STRAND       73     75       {ECO:0000244|PDB:1DNL}.
FT   STRAND       78     84       {ECO:0000244|PDB:1DNL}.
FT   HELIX        88     95       {ECO:0000244|PDB:1DNL}.
FT   STRAND       98    103       {ECO:0000244|PDB:1DNL}.
FT   HELIX       106    108       {ECO:0000244|PDB:1DNL}.
FT   STRAND      110    120       {ECO:0000244|PDB:1DNL}.
FT   HELIX       123    130       {ECO:0000244|PDB:1DNL}.
FT   HELIX       135    143       {ECO:0000244|PDB:1DNL}.
FT   HELIX       154    166       {ECO:0000244|PDB:1DNL}.
FT   STRAND      167    170       {ECO:0000244|PDB:1G79}.
FT   STRAND      178    183       {ECO:0000244|PDB:1DNL}.
FT   STRAND      186    192       {ECO:0000244|PDB:1DNL}.
FT   HELIX       195    197       {ECO:0000244|PDB:1DNL}.
FT   STRAND      200    206       {ECO:0000244|PDB:1DNL}.
FT   STRAND      208    215       {ECO:0000244|PDB:1DNL}.
SQ   SEQUENCE   218 AA;  25545 MW;  8B47CEEEA6CEF5F9 CRC64;
     MSDNDELQQI AHLRREYTKG GLRRRDLPAD PLTLFERWLS QACEAKLADP TAMVVATVDE
     HGQPYQRIVL LKHYDEKGMV FYTNLGSRKA HQIENNPRVS LLFPWHTLER QVMVIGKAER
     LSTLEVMKYF HSRPRDSQIG AWVSKQSSRI SARGILESKF LELKQKFQQG EVPLPSFWGG
     FRVSLEQIEF WQGGEHRLHD RFLYQRENDA WKIDRLAP
//
